Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining

BMC Immunology

Volumn 11, Issue , 2010, Pages

  Smith, Steven G ^a   Lalor, Maeve K ^a   Gorak Stolinska, Patricia ^a   Blitz, Rose ^a   Beveridge, Natalie E R ^b   Worth, Andrew ^b   McShane, Helen ^b   Dockrell, Hazel M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NIHR Biomedical Researcg Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; TUMOR NECROSIS FACTOR ALPHA; BCG VACCINE; BIOLOGICAL MARKER; CYTOKINE; MICROSPHERE; TUBERCULIN;

ADOLESCENT; ARTICLE; BCG VACCINATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN EXPRESSION; STAINING; UNITED KINGDOM; BIOSYNTHESIS; BLOOD; IMMUNOASSAY; IMMUNOLOGY; INTRACELLULAR SPACE; METABOLISM; METHODOLOGY; TUBERCULOSIS; VACCINATION;

ADOLESCENT; BCG VACCINE; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FLOW CYTOMETRY; GREAT BRITAIN; HUMANS; IMMUNOASSAY; INTERFERON-GAMMA; INTRACELLULAR SPACE; KILLER CELLS, NATURAL; MICROSPHERES; MYCOBACTERIUM TUBERCULOSIS; STAINING AND LABELING; TUBERCULIN; TUBERCULOSIS; VACCINATION;

EID: 77954288837     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-11-35     Document Type: Article

References (34)

1. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993, 178:2243-7. 10.1084/jem.178.6.2243, 2191280, 8245795.
2. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993, 178:2249-54. 10.1084/jem.178.6.2249, 2191274, 7504064.
3. Ottenhoff TH, De Boer T, van Dissel JT, Verreck FA. Human deficiencies in type-1 cytokine receptors reveal the essential role of type-1 cytokines in immunity to intracellular bacteria. Adv Exp Med Biol 2003, 531:279-94.
4. Pai M, Riley LW, Colford JM. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004, 4:761-76. 10.1016/S1473-3099(04)01206-X, 15567126.
5. Jacobs M, Togbe D, Fremond C, Samarina A, Allie N, Botha T, Carlos D, Parida SK, Grivennikov S, Nedospasov S, et al. Tumor necrosis factor is critical to control tuberculosis infection. Microbes Infect 2007, 9:623-8. 10.1016/j.micinf.2007.02.002, 17409008.
6. Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE, Shen F, Eaton SM, Gaffen SL, Swain SL, et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007, 8:369-77. 10.1038/ni1449, 17351619.
7. Goletti D, Butera O, Bizzoni F, Casetti R, Girardi E, Poccia F. Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis. J Infect Dis 2006, 194:984-92. 10.1086/507427, 16960787.
8. Shen Y, Zhou D, Qiu L, Lai X, Simon M, Shen L, Kou Z, Wang Q, Jiang L, Estep J, et al. Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science 2002, 295:2255-8. 10.1126/science.1068819, 2872146, 11910108.
9. Cohen NR, Garg S, Brenner MB. Antigen Presentation by CD1 Lipids, Cells T, and NKT Cells in Microbial Immunity. Adv Immunol 2009, 102:1-94. full_text, 19477319.
10. Cooper AM. T cells in mycobacterial infection and disease. Curr Opin Immunol 2009, 21:378-84. 10.1016/j.coi.2009.06.004, 19646851.
11. Rook GA. Th2 cytokines in susceptibility to tuberculosis. Curr Mol Med 2007, 7:327-37. 10.2174/156652407780598557, 17504117.
12. Sharma PK, Saha PK, Singh A, Sharma SK, Ghosh B, Mitra DK. FoxP3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis. Am J Respir Crit Care Med 2009, 179:1061-70. 10.1164/rccm.200804-529OC, 19246720.
13. Hart PD, Sutherland I. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br Med J 1977, 2:293-5. 10.1136/bmj.2.6082.293, 1630784, 326347.
14. Black GF, Weir RE, Floyd S, Bliss L, Warndorff DK, Crampin AC, Ngwira B, Sichali L, Nazareth B, Blackwell JM, et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 2002, 359:1393-401. 10.1016/S0140-6736(02)08353-8, 11978337.
15. Biselli R, Mariotti S, Sargentini V, Sauzullo I, Lastilla M, Mengoni F, Vanini V, Girardi E, Goletti D, D'Amelio D, et al. Detection of IL-2 in addition to IFN-gamma discriminates active tuberculosis patients, latently infected individuals and controls. Clin Microbiol Infect 2009,
16. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001, 345:1098-104. 10.1056/NEJMoa011110, 11596589.
17. Soares AP, Scriba TJ, Joseph S, Harbacheuski R, Murray RA, Gelderbloem SJ, Hawkridge A, Hussey GD, Maecker H, Kaplan G, et al. Bacillus calmette-guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J Immunol 2008, 180:3569-77. 2842001, 18292584.
18. Lalor MK, Smith SG, Floyd S, Gorak-Stolinska P, Weir RE, Blitz R, Branson K, Fine PE, Dockrell HM. Complex cytokine profiles induced by BCG vaccination in UK infants. Vaccine 2010, 28:1635-41. 10.1016/j.vaccine.2009.11.004, 2824844, 19941997.
19. Beveridge NE, Price DA, Casazza JP, Pathan AA, Sander CR, Asher TE, Ambrozak DR, Precopio ML, Scheinberg P, Alder NC, et al. Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations. Eur J Immunol 2007, 37:3089-100. 10.1002/eji.200737504, 2365909, 17948267.
20. Ottenhoff TH, Kumararatne D, Casanova JL. Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol Today 1998, 19:491-4. 10.1016/S0167-5699(98)01321-8, 9818540.
21. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001, 19:93-129. 10.1146/annurev.immunol.19.1.93, 11244032.
22. Stenger S. Immunological control of tuberculosis: role of tumour necrosis factor and more. Ann Rheum Dis 2005, 64(Suppl 4):iv24-8. 10.1136/ard.2005.042531, 1766911, 16239381.
23. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-12. 10.1038/44385, 10537110.
24. Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003, 171:6173-7.
25. Molet S, Hamid Q, Davoine F, Nutku E, Taha R, Page N, Olivenstein R, Elias J, Chakir J. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001, 108:430-8. 10.1067/mai.2001.117929, 11544464.
26. Lockhart E, Green AM, Flynn JL. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 2006, 177:4662-9.
27. Umemura M, Yahagi A, Hamada S, Begum MD, Watanabe H, Kawakami K, Suda T, Sudo K, Nakae S, Iwakura Y, et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J Immunol 2007, 178:3786-96.
28. Smith SM, Malin AS, Pauline T, Lukey, Atkinson SE, Content J, Huygen K, Dockrell HM. Characterization of human Mycobacterium bovis bacille Calmette-Guerin-reactive CD8+ T cells. Infect Immun 1999, 67:5223-30. 96874, 10496899.
29. Scriba TJ, Kalsdorf B, Abrahams DA, Isaacs F, Hofmeister J, Black G, Hassan HY, Wilkinson RJ, Walzl G, Gelderbloem SJ, et al. Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol 2008, 180:1962-70. 2219462, 18209095.
30. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, Sallusto F, Napolitani G. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007, 8:639-46. 10.1038/ni1467, 17486092.
31. Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 2008, 8:247-58. 10.1038/nri2274, 18323851.
32. McShane H, Pathan AA, Sander CR, Keating SM, Gilbert SC, Huygen K, Fletcher HA, Hill AV. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat Med 2004, 10:1240-4. 10.1038/nm1128, 15502839.
33. Garcia-Pineres A, Hildesheim A, Dodd L, Kemp TJ, Williams M, Harro C, Lowy DR, Schiller JT, Pinto LA. Cytokine and chemokine profiles following vaccination with human papillomavirus type 16 L1 Virus-like particles. Clin Vaccine Immunol 2007, 14:984-9. 10.1128/CVI.00090-07, 2044489, 17596432.
34. Pinto LA, Castle PE, Roden RB, Harro CD, Lowy DR, Schiller JT, Wallace D, Williams M, Kopp W, Frazer IH, et al. HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood. Vaccine 2005, 23:3555-64. 10.1016/j.vaccine.2005.01.146, 15855014.